Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
ConditionOCD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHan Joo Lee
About this trial
Thought-Action-Fusion (TAF) is a cognitive bias that posits (1) having unwanted thoughts is morally equivalent to acting upon the thoughts (TAF-Moral; e.g., "Thinking about harming a child is as immoral as actually harming a child") and (2) having unwanted thoughts will increase the likelihood of the thoughts happening in real life (TAF-Likelihood; e.g., "My mother will get into a car accident, because I thought about it"). Given its central role in the development and maintenance of OCD, TAF has emerged as a potential treatment target for obsessive-compulsive disorder (OCD). Previous research has demonstrated that TAF is indeed a malleable construct. This study aims to examine the effects of a multi-session, personalized cognitive bias modification (CBM) for thought-action-fusion (TAF) on improving obsessive-compulsive (OC) symptoms in a college sample.
Eligibility criteria
Qualifiers
A score of 18 or higher on the Dimensional Obsessive-Compulsive Scale (DOCS)
Aged 18 or higher
Access to a mobile device (i.e., smartphone)
Disqualifiers
Self-reported visual impairment that cannot be adjusted and will prevent them from clearly recognizing words and pictures on mobile screen
Self-reported history of a bipolar disorder or psychotic disorder on a Diagnostic History Scale (DHS)
Inability to adequately understand the study procedure as determined by the responses to comprehension questions provided at the time of the consent
Trial design
Treatments tested in this trial
- CBM-TAF
- CBM-SMP
Treatment groups
84 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov